跳至主要内容
临床试验/EUCTR2015-002506-37-SE
EUCTR2015-002506-37-SE进行中(未招募)1 期

Dexmedetomidine for analgosedation to newborn infants during neonatalintensive care – a prospective pharmacokinetic/ pharmacodynamic/pharmacogenetic observational study.Cohort 3 in The SANNI Project.

Region Skane0 个研究点目标入组 100 人开始时间: 2019年9月30日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Region Skane
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Newborn infants
  • - born 34+0 gw with a need for dexmedetomidine for analgesic
  • and/or sedative treatment after postnatal surgical correction of
  • congenital malformations and who will be cared for in the
  • PICU/postoperative unit and in a some few cases in the NICU, or
  • - with a corresponding age of 37 gw, who are in need for
  • dexmedetomidine according to clinical judgment (scoring with pain
  • assessment scales; ALPS-Neo and Comfort-Neo) and cared for in the
  • Existing arterial or venous cannulas/catheters for repeated nontraumatic
  • blood sampling
  • Informed and written parental consent obtained before study start.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 100
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Infant older than age corresponding to gw 46+0
  • Previous treatment with the dexmedetomidine or clonidine within 72 hours (only for postoperative infants).
  • Congenital cardiac malformations requiring surgery on extracorporeal circulation and treatment with hypothermia.
  • Ongoing renal replacement treatment
  • Any serious medical condition or ethical issues that could, in the investigators opinion, interfere with the study procedures.

研究者

发起方
Region Skane

相似试验